Tri Locum Partners LP Theravance Biopharma, Inc. Transaction History

Tri Locum Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $958,604 - $1.43 Million	-129,192 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $874,629 - $1.86 Million	129,192 New	129,192 $956,000
Q1 2021 May 17, 2021	SELL	$16.57 - $21.08 $818,110 - $1.04 Million	-49,373 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.89 - $20.16 $735,163 - $995,359	49,373 New	49,373 $877,000

134

48.6M

13.9K

3.1K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $550M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.